Aortic pathology and Marfan syndrome
Aortic diseases are relatively common, affecting 5% of the population over the age of 65. Abdominal affectation is much more common in the elderly, while affectation of the thoracic aorta is more likely to occur among younger people.
The main problem is that due to the lack of symptoms it can go unnoticed and is often diagnosed through a study using imaging techniques such as echocardiography or CT. The aorta is almost always prone to dilation and aneurysm before rupture, which is why it is very important to diagnose the problem early and to try to slow it down.
Why does a transversal line make sense for treating aortic disease?
Classically this condition has been treated by surgeons. In recent years it has been proven that the only way to improve diagnosis and treatment is to treat the subject in a multidisciplinary manner. Certainly, when the aorta is broken it is vital to offer prompt, careful surgical treatment, but the medical goal is to try not to break it, or to indicate the surgery before the risk is too high. There are two reasons behind aortic disease developing. Firstly, we find genetic disorders such as Marfan syndrome, bicuspid aorta, etc. And on the other hand, we find hypertension or atherosclerosis. It is therefore very important to have a genetics unit, to take into account family history and risk factors, excellent support through imaging techniques (echocardiography, CT and MRI) and a good cardiovascular surgery team. The Multidisciplinary Aortic Diseases Unit at the Vall d'Hebron University Hospital was set up because most of these requirements are already met.
When did we start and how have we evolved?
For 20 years now we have been monitoring all sick people receiving medical discharge after having overcome an acute aortic syndrome, which is a risky condition that can lead to very serious complications. We are one of the leading groups in the protocolised monitoring of this disease. This experience has provided us with a unique knowledge of this disease.
More recently, our interest has expanded to genetic or congenital diseases that may affect the aorta. An important turning point was the creation of the Marfan Syndrome Multidisciplinary Unit in 2009. This Unit, a leading centre in Catalonia, has the purpose of offering patients integral assistance for all their related problems.
To improve the care provided for aortic pathology in terms of prevention, diagnosis and treatment.
Prevention and diagnosis
To inform specialists and general practitioners when the disease should be suspected: family history, genetic diseases, valvular heart disease, atherosclerosis. Proper diagnostic strategy and control of risk factors (ADHD, smoking, etc.)
Surgical / endovascular treatment
Appropriate indications, selection of cases, and intraoperative support for optimisation of surgical or endovascular treatment, in both urgent and scheduled actions.
The former head of the Thoracic Surgery Department, Dr. Mercè Canela, recently retired, recalls the important evolution of the Department to become a leader in Spain and a lung transplant pioneer. A task made possible thanks to collaboration with professionals from other departments, an added value in the personal and team environment.
Rosalia Moure arrived at Vall d’Hebron University Hospital in 1967. She spent her entire working life in the linen and laundry department of the Hospital. Rosalia Moure has witnessed the Hospital’s big transformations, from dictatorship to democracy and from analogue to digital systems.
Dr. Josep Sánchez de Toledo Codina, head of the Paediatric Haematology and Oncology Department, tells us about a Department that has laid the foundations for the specialism in Spain. He also remembers the evolution of transplants from haematopoietic stem cells and progenitors, from the beginning, buying the material at a shop in Barcelona city centre, to the more than 1,200 transplants that have now been performed.
Dr. Francesc Bosch, Head of the Haematology Department, talks about the complexity of the Department, which has turned Vall d’Hebron into a reference centre in haematology thanks to its commitment to transplants and the use of new treatments. The Clinical Trials Unit helps a lot, giving access to treatments for complex patients.
The Master's Degree in Biomedical and Translational Research is an official programme created to train researchers with the requisite combination of scientific knowledge and skills to contribute to the future success of biomedical research.
Fermín Fernández Álvarez, Porter Coordinator, explains the importance of the role these professionals play in the hospital. After 36 years at Vall d’Hebron, Fermín is a real master of the ways things are done. He says that a porter has to combine humility, discretion and safety with a single goal: that patients receive human and friendly treatment.
The constant search for excellence is part of Hospital Vall d’Hebron’s nature. The biggest hospital in Catalonia and the leader in many fields, headed since February 2015 by Dr. Vicenç Martínez Ibáñez, who has a close personal and professional relationship with the Hospital. Dr. Martínez Ibáñez says that if Vall d’Hebron did not exist, it would need to be invented. The current director trained at the hospital, where he was one of the protagonists of an historic moment: the first paediatric liver transplant in Spain. Now, he is committed to continuing this legacy and, always putting the patient first, achieving excellence across all staff.